Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic Effects of Iloperidone vs Olanzapine in Healthy Adults
NCT01920802Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Nov 2012
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of iloperidone in schizophrenia, bipolar disorder (BD), sponsored by New York State Psychiatric Institute. Started Nov 2012; status: completed.
02
Drugs
iloperidone
03
Conditions
schizophreniabipolar disorder (BD)
Beyond the preview
Go deeper on NCT01920802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01920802.